Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.AuthorsAbdul Razak, Albiruni R.; Miller, Wilson H.; Uy, Geoffrey L.; Blotner, Steven; Young, Anne-Marie; Higgins, Brian; Chen, Lin-Chi; Gore, LiaPublicationInvestigational New Drugs, 2020, Vol 38, Issue 4, p1156ISSN0167-6997Publication typeArticleDOI10.1007/s10637-019-00869-2